TY  - GEN
AU  - Li,Zhi-Ming
AU  - Huang,Jia-Jia
AU  - Xia,Yi
AU  - Sun,Jian
AU  - Huang,Ying
AU  - Wang,Yu
AU  - Zhu,Ying-Jie
AU  - Li,Ya-Jun
AU  - Zhao,Wei
AU  - Wei,Wen-Xiao
AU  - Lin,Tong-Yu
AU  - Huang,Hui-Qiang
AU  - Jiang,Wen-Qi
TI  - Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP
SN  - 1932-6203
PY  - 2013///0222
KW  - Aged
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Leukocyte Count
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - blood
KW  - Male
KW  - Middle Aged
KW  - Monocytes
KW  - pathology
KW  - Multivariate Analysis
KW  - Prednisone
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - ROC Curve
KW  - Risk Factors
KW  - Rituximab
KW  - Treatment Outcome
KW  - Vincristine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1371/journal.pone.0041658
ER  -